NW Dermatology & Research Center, LLC

Portland, Oregon 97210

We've found

1 trials

at this facility

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Portland, OR

Use our guide to learn which trials are right for you!